RUNX1 and acute lymphoblastic leukemia: OCT4, Nanog, and SOX2 expression was significantly increased in BCP-ALL cells treated with IP (Fig. 1C and D), as was AML1, ETV6, and Ikaros1 mRNA expression (Fig. 1E and F).